Faster, cheaper test can help predict risk of metastasis in prostate cancer patients

A report describes a new assay to assess copy number alterations that is cheaper, faster, reproducible, and requires less tissue than other diagnostic techniques and has the potential to significantly enhance prostate cancer evaluation.

Leave a Reply

Your email address will not be published.